FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More
FDA
5 drugs now in shortage
(By Paige Twenter for Becker’s Hospital Review) About two-thirds of providers recently told Premier their teams are spending more than
Read MoreThe FDA Calls Them ‘Recalls,’ Yet the Targeted Medical Devices Often Remain in Use
(By David Hilzenrath for KFF Health News) In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac
Read MoreFDA calls out Bristol Myers over cancer drug claims
(By Elizabeth Gregerson for Becker’s Hospital Review) The FDA has accused pharmaceutical company Bristol Myers Squibb of making false or
Read MoreFDA gives thumbs down to MDMA for now, demanding further research
(By Will Stone for NPR) On Friday, drugmaker Lykos Therapeutics received word from the Food and Drug Administration that the
Read MoreCan a lobbying push led by veterans help MDMA get approved for PTSD treatment?
(By Will Stone for NPR) Working in the music industry, Rogers Masson traveled in plenty of circles where ecstasy made
Read MoreHospitals, labs, and health departments try to cope with blood culture bottle shortage
(By Helen Branswell for STAT) Hospitals across the country are facing a severe shortage of supplies of blood culture bottles,
Read MoreFDA approves a second Alzheimer’s drug that can modestly slow disease
By The Associated Press NPR July 2, 2024 WASHINGTON — U.S. officials have approved another Alzheimer’s drug that can modestly slow
Read MoreFDA approves 1st inhaled COPD treatment in 20 years
(By Ashleigh Hollowell for Becker’s Hospital Review) An inhalable drug treatment for chronic obstructive pulmonary disease received FDA-approval June 26,
Read MoreHealth insurers cover fewer drugs and make them harder to get
(By Sydney Lupkin for NPR) Insurance coverage isn’t what it used to be when it comes to prescription drugs. Insurance
Read More